JNJ

227.44

-0.31%↓

ISRG

504.69

-0.03%↓

ABT

109.07

+2.8%↑

MDT

102.62

+1.64%↑

133.31

+0.25%↑

JNJ

227.44

-0.31%↓

ISRG

504.69

-0.03%↓

ABT

109.07

+2.8%↑

MDT

102.62

+1.64%↑

133.31

+0.25%↑

JNJ

227.44

-0.31%↓

ISRG

504.69

-0.03%↓

ABT

109.07

+2.8%↑

MDT

102.62

+1.64%↑

133.31

+0.25%↑

JNJ

227.44

-0.31%↓

ISRG

504.69

-0.03%↓

ABT

109.07

+2.8%↑

MDT

102.62

+1.64%↑

133.31

+0.25%↑

JNJ

227.44

-0.31%↓

ISRG

504.69

-0.03%↓

ABT

109.07

+2.8%↑

MDT

102.62

+1.64%↑

133.31

+0.25%↑

Kodu・Aktsiate loetelu・Gossamer Bio Inc

Gossamer Bio Inc

Avatud

SektorTervishoid

2.3 -6.88

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.29

Max

2.48

Põhinäitajad
By Trading Economics
Sissetulek	-9.9M -48M
Müük	1.8M 13M
Kasumimarginaal	-362.728
Töötajad	144
EBITDA	-10M -45M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+350.98% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	11. märts 2026

Turustatistika
By TradingEconomics
Turukapital	69M 616M
Eelmine avamishind	9.18
Eelmine sulgemishind	2.3

Uudiste sentiment

By Acuity

65%

35%

308 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

1.06 / 1.23 Toetus ja vastupanu

Gossamer Bio Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. jaan 2026, 22:31 UTC

Tulu

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29. jaan 2026, 22:05 UTC

Tulu

Stryker Logs Higher 4Q Profit On Sales Gains

29. jaan 2026, 21:54 UTC

Tulu

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29. jaan 2026, 21:36 UTC

Tulu

Visa 1Q Sales Climb on Strong Holiday Shopping

29. jaan 2026, 23:57 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29. jaan 2026, 23:56 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29. jaan 2026, 23:53 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29. jaan 2026, 23:51 UTC

Tulu

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29. jaan 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29. jaan 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29. jaan 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29. jaan 2026, 23:35 UTC

Tulu

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29. jaan 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29. jaan 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29. jaan 2026, 23:15 UTC

Market Talk

Tulu

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29. jaan 2026, 22:27 UTC

Tulu

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29. jaan 2026, 22:27 UTC

Tulu

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29. jaan 2026, 22:12 UTC

Tulu

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29. jaan 2026, 21:55 UTC

Tulu

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

29. jaan 2026, 21:50 UTC

Tulu

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Health Care Roundup: Market Talk

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Auto & Transport Roundup: Market Talk

29. jaan 2026, 21:49 UTC

Tulu

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29. jaan 2026, 21:46 UTC

Tulu

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29. jaan 2026, 21:36 UTC

Tulu

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29. jaan 2026, 21:32 UTC

Tulu

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29. jaan 2026, 21:32 UTC

Tulu

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29. jaan 2026, 21:30 UTC

Tulu

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29. jaan 2026, 21:30 UTC

Tulu

Apple 1Q Mac Rev $8.39B >AAPL

Võrdlus sarnastega

Hinnamuutus

Gossamer Bio Inc Prognoos

Hinnasiht

By TipRanks

350.98% tõus

12 kuu keskmine prognoos

Keskmine 11.5 USD 350.98%

Kõrge 15 USD

Madal 9 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Gossamer Bio Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Gossamer Bio Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

1.06 / 1.23Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

308 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.